Healthcare Strategy, Simplified

Who We Are

At Artegist, we are a healthcare consultancy specialized in governance, strategy and execution for companies operating in regulated markets, blending deep expertise with a personal touch to guide strategic growth and achieve concrete results.

˜05 countries

in Europe and LATAM portfolio analyses

US$1 million+

annual revenue generated to a single client

+40 therapeutic class

analyses for Biotech, Rx, CH, OTC and Medtech

Healthcare Market

Healthcare is a vast market, but growth depends on navigating complex regulatory, commercial and governance pathways.

CH (Consumer Health)

The Consumer Health market is shifting from treatment to performance, and winning brands combine data, personalization and governance to scale in a consolidating US$300B+ arena.

OTC (Over-The-Counter Medicines)

OTC is no longer just mass medicine: digital channels, Rx-to-OTC switches and stricter compliance are reshaping a US$150B+ market where strategy defines who captures growth.

Rx (Prescription Drugs)

In a trillion-dollar Rx market moving toward specialty, biologics and real-world evidence, growth depends less on scale and more on disciplined strategy and governance under pricing pressure.

Medtech

Medtech growth is driven by focused clinical niches, partnerships and execution, turning innovation into value in a US$500B+ market shaped by data, AI and regulation.